Last synced on 30 May 2025 at 11:05 pm

Braf Mutation Kit

Page Type
Product Code
Definition
The BRAF mutation kit is a multiplex qualitative in vitro diagnostic device to identify specific BRAF mutations by multiplex polymerase chain reaction of genomic DNA extracted from formalin-fixed paraffin-embedded (FFPE) colorectal cancer or fine needle aspirated (FNA) thyroid tissue. It is intended to aid in the treatment decisions and risk stratification of patients diagnosed with colorectal or papillary thyroid cancer.
Physical State
Multiplex qualitative DNA mutation amplification and detection test system. Should not include products not intended for export only or for products intended for re-importation into the USA.
Technical Method
The test uses multiplex qualitative polymerase chain reaction (PCR) and a multiplex test system (e.g., liquid bead array cytometry, etc.) to amplify and detect specific BRAF mutations.
Target Area
Formalin-fixed paraffin-embedded (FFPE) colorectal cancer or fine needle aspirated (FNA) thyroid tissue.
Review Panel
Pathology
Submission Type
Contact ODE
Device Classification
N
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

As product code PAN is assigned to devices that are "not-classified", it is not linked to any specific regulation and CFR section.

Braf Mutation Kit

Page Type
Product Code
Definition
The BRAF mutation kit is a multiplex qualitative in vitro diagnostic device to identify specific BRAF mutations by multiplex polymerase chain reaction of genomic DNA extracted from formalin-fixed paraffin-embedded (FFPE) colorectal cancer or fine needle aspirated (FNA) thyroid tissue. It is intended to aid in the treatment decisions and risk stratification of patients diagnosed with colorectal or papillary thyroid cancer.
Physical State
Multiplex qualitative DNA mutation amplification and detection test system. Should not include products not intended for export only or for products intended for re-importation into the USA.
Technical Method
The test uses multiplex qualitative polymerase chain reaction (PCR) and a multiplex test system (e.g., liquid bead array cytometry, etc.) to amplify and detect specific BRAF mutations.
Target Area
Formalin-fixed paraffin-embedded (FFPE) colorectal cancer or fine needle aspirated (FNA) thyroid tissue.
Review Panel
Pathology
Submission Type
Contact ODE
Device Classification
N
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

As product code PAN is assigned to devices that are "not-classified", it is not linked to any specific regulation and CFR section.